Initial Consultation for SBIR Grant-Writing Strategy
Congratulations! You were highly recommended to us, and we would like to start working more closely with you to refine our grant funding strategy.
More importantly, we would like for you to review the following documents that articulate more about our current aims and research strategy:
020314_CancerIQ Grant Planning Strategy
020314_CancerIQ Clinical Guidance - Specific Aims & Research Strategy
020314_CancerIQ Cancer Risk Management - Specific Aims & Research Strategy
For the clinically-facing applications, we are a great candidate for the PA-12-196: Innovative Health Information Technology for Broad Adoption by Healthcare Systems and Consumers (SBIR) (R44). We also feel that we are a strong candidate for the PCORI: Assessment of Prevention, Diagnosis, and Treatment Options opportunity.
For the CancerIQ Research Portal product, we are still seeking the most appropriate funding opportunity, including an STTR grant (because the software was licensed from a University).
We are very excited to work with someone who is so vastly experienced in SBIR grant writing, and look forward to kicking off this original consulting assignement as soon as possible.
Based on your advice, we will progress towards awarding a fixed bid contract to lead the grant writing process for us.
Once you have executed an NDA, we will share the documents described above.